Abstract
• Group B streptococcus and Escherichia coli account for most of the cases of neonatal early-onset bacterial sepsis. • Prevention of infection by maternal treatment is the main factor accounting for the decreased incidence of early-onset group B streptococcus sepsis. • Microbiologic cultures represent the mainstay for diagnosis of infection. • Management of the asymptomatic newborn at risk of infection because of maternal risk factors is in transition, with recent evidence supporting evaluation and treatment of a small proportion of asymptomatic infants. • Ampicillin and gentamicin are recommended as initial therapy in neonates with suspected bacterial sepsis. Treatment can then be narrowed appropriately on the basis of the results of antibiotic susceptibility studies.
Original language | English (US) |
---|---|
Title of host publication | Avery's Diseases of the Newborn, Tenth Edition |
Publisher | Elsevier |
Pages | 553-565.e3 |
ISBN (Electronic) | 9780323401395 |
ISBN (Print) | 9780323401739 |
DOIs | |
State | Published - Jan 1 2017 |
Bibliographical note
Publisher Copyright:© 2018 Elsevier Inc. All rights reserved.
Keywords
- E coli
- Neonatal sepsis
- Risk factors for neonatal sepsis
- Streptococcus, Group B
- Treatment of neonatal sepsis